Claude AI Says Market is Ignoring Ardelyx (ARDX) Growth Catalysts
Ardelyx, Inc (NASDAQ:ARDX) is a biotech company. It makes drugs for gut and kidney conditions.
Hedge Funds
News & Analysis
Top Fund Managers
Best Performing Funds
Featured Content
Insider Trading
News & Analysis
Latest Insider Purchases
Mahai bought 527 Abrdn Life Sciences Investors shares at $19.92
Mahai bought 501 Abrdn Healthcare Investors shares at $20.96
Mahai bought 796 Abrdn World Healthcare Fund shares at $13.20
Mahai bought 568 Abrdn Healthcare Opportunities Fund shares at $18.49
Mcgarity bought 140,000 Greenland Mines Ltd shares at $0.18
Latest Insider Sales
Innovative sold 10 Lyell Immunopharma Inc. shares at $13.70
Johnson sold 1,000 Epr Properties shares at $62.50
Saba sold 83,087 Blackrock Esg Capital Allocation Term Trust shares at $15.35
Saba sold 32,854 Blackrock Esg Capital Allocation Term Trust shares at $15.62
Sitaram sold 1,732 Doximity Inc. shares at $22.02
Featured Content
Do not Miss


































